Outcome predictors affecting the efficacy of clonazepam therapy for the management of burning mouth syndrome (BMS)-Reference-Cited by-同舟云学术

Outcome predictors affecting the efficacy of clonazepam therapy for the management of burning mouth syndrome (BMS)

Published:2012-11 Issue:3 Volume:55 Page:755-761
ISSN:0167-4943
Container-title:Archives of Gerontology and Geriatrics
language:en
Short-container-title:Archives of Gerontology and Geriatrics

Author:

Ko Ji-Young,Kim Moon-Jong,Lee Sang-Goo,Kho Hong-Seop

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Gerontology,Aging,Health (social science)

Reference41 articles.

1. Combined topical and systemic clonazepam therapy for the management of burning mouth syndrome: a retrospective pilot study;Amos;J. Orofac. Pain,2011

2. Taste damage: previously unsuspected consequences;Bartoshuk;Chem. Senses,2005

3. Burning mouth syndrome: literature review and model for research and management;Bergdahl;J. Oral Pathol. Med.,1993

4. Burning mouth syndrome: prevalence and associated factors;Bergdahl;J. Oral Pathol. Med.,1999

5. Personality characteristics of patients with resistant burning mouth syndrome;Bergdahl;Acta Odontol. Scand.,1995

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Burning Mouth Syndrome;Dental Clinics of North America;2024-01

2. Xerostomia, reduced salivary flow, and oral burning: Associations from a cross-sectional study;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2023-08

3. Therapeutic effects of clonazepam in patients with burning mouth syndrome and various symptoms or psychological conditions;Scientific Reports;2023-05-04

4. Treatment for Burning Mouth Syndrome: A Clinical Review;Journal of Oral Medicine and Pain;2023-03-30

5. Xerogenic medications may contribute to decreased unstimulated salivary flow in patients with oral burning and/or gastro-esophageal reflux disease;Frontiers in Dental Medicine;2023-02-23